Asymmetry on large scale: the roadmap to stereoselective processes

In recent years there has been a movement in drug discovery and development away from chemical processes that produce racemic compounds towards those that produce stereochemically defined products. Asymmetric reactions are an attractive way to produce such products. Here, I discuss the factors that are important in deciding whether using an asymmetric reaction is the most appropriate approach for the large-scale synthesis of a stereochemically defined pharmaceutical compound, and highlight progress in the development of large-scale stereoselective processes.

[1]  Hans-Jürgen Federsel,et al.  Facing chirality in the 21st century: Approaching the challenges in the pharmaceutical industry. , 2003, Chirality.

[2]  H. Brunner,et al.  Enantioselective catalysis, 85 , 1994 .

[3]  Ian Paterson,et al.  Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 5: Linkage of Fragments C1-6 and C7-24 and Finale , 2004 .

[4]  M. J. Sabacky,et al.  Catalytic asymmetric hydrogenation employing a soluble, optically active, rhodium complex , 1968 .

[5]  B. D. Vineyard,et al.  Asymmetric hydrogenation. Rhodium chiral bisphosphine catalyst , 1977 .

[6]  V. T. Perchyonok,et al.  Remarkable Lewis acid mediated enhancement of enantioselectivity during free-radical reductions by simple chiral non-racemic stannanes , 1999 .

[7]  G. Rothenberg,et al.  Optimal Heck Cross‐Coupling Catalysis: A Pseudo‐Pharmaceutical Approach , 2003 .

[8]  J. Gras.  By Asymmetric Hydrogenation , 2007 .

[9]  A. Maureen Rouhi,et al.  ORGANOZIRCONIUM CHEMISTRY ARRIVES , 2004 .

[10]  Jaemoon Yang,et al.  Influence of a β-Alkoxy Substituent on the C—H Activation Chemistry of Alkyl Ethers. , 2004 .

[11]  F. Tanaka,et al.  Enamine-based organocatalysis with proline and diamines: the development of direct catalytic asymmetric Aldol, Mannich, Michael, and Diels-alder reactions. , 2004, Accounts of chemical research.

[12]  A. Hutt,et al.  Stereoselectivity in Drug Action and Disposition: An Overview , 2004 .

[13]  E. Jacobsen,et al.  Privileged Chiral Catalysts , 2003, Science.

[14]  K. Mislow.  Stereochemical terminology and its discontents. , 2002, Chirality.

[15]  G. R. Tombo,et al.  Chirality and Crop Protection , 1991 .

[16]  S. Xue,et al.  Large-scale synthesis of the anti-cancer marine natural product (+)-discodermolide. Part 1: Synthetic strategy and preparation of a common precursor , 2004 .

[17]  E. Fischer,et al.  Ueber die Bildung der Phenylhydrazide , 1889 .

[18]  K. Nicolaou,et al.  Total Synthesis of Apoptolidin: Construction of Enantiomerically Pure Fragments. , 2004 .

[19]  D. Mathre,et al.  An Asymmetric Synthesis of MK-0417. Observations on Oxazaborolidine- Catalyzed Reductions. , 1991 .

[20]  K. Faber,et al.  Biocatalytic Deracemization Techniques: Dynamic Resolutions and Stereoinversions , 1997 .

[21]  Harry B Gray,et al.  Oxoiron(IV) in Chloroperoxidase Compound II Is Basic: Implications for P450 Chemistry , 2004, Science.

[22]  A. Maureen Rouhi,et al.  Chirality at work , 2003 .

[23]  Giles R. Scuderi,et al.  The Basic Principles , 2006 .

[24]  Ryoji Noyori Prof..  Asymmetric Catalysis: Science and Opportunities (Nobel Lecture) , 2002 .

[25]  Hans-Ulrich Blaser.  The Chiral Switch of (S)‐Metolachlor: A Personal Account of an Industrial Odyssey in Asymmetric Catalysis , 2002 .

[26]  Y. Choi,et al.  Lipase/ruthenium-catalyzed dynamic kinetic resolution of hydroxy acids, diols, and hydroxy aldehydes protected with a bulky group. , 2001, The Journal of organic chemistry.

[27]  T. Ramsey,et al.  Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 4: Preparation of Fragment C7-24 , 2004 .

[28]  S. Schaus,et al.  Highly Selective Hydrolytic Kinetic Resolution of Terminal Epoxides Catalyzed by Chiral (Salen)CoIII Complexes. Practical Synthesis of Enantioenriched Terminal Epoxides and 1,2-Diols. , 2002 .

[29]  Bernhard Hauer,et al.  Industrial methods for the production of optically active intermediates. , 2004, Angewandte Chemie.

[30]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[31]  J. Gladysz.  Introduction: recoverable catalysts and reagents-perspective and prospective. , 2002, Chemical reviews.

[32]  Hanna Cotton,et al.  Asymmetric synthesis of esomeprazole , 2000 .

[33]  D. Voehringer,et al.  Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase. , 2001, Chemistry & biology.

[34]  A. Hirao,et al.  Asymmetric reduction of aromatic ketones with chiral alkoxy-amineborane complexes , 1981 .

[35]  R. Madsen,et al.  Enyne Metathesis Catalyzed by Ruthenium Carbene Complexes , 2003 .

[36]  P. Jaksch,et al.  An efficient synthesis of a new, chiral 2',6'-pipecoloxylidide local anaesthetic agent , 1987 .

[37]  K. Sharpless,et al.  Searching for new reactivity (Nobel lecture). , 2002, Angewandte Chemie.

[38]  Ryoji Noyori,et al.  Asymmetric catalysis: science and opportunities (Nobel lecture). , 2002, Angewandte Chemie.

[39]  Hans-Jürgen Federsel,et al.  Searching for scalable processes: addressing the challenges in times of increasing complexity. , 2003, Current opinion in drug discovery & development.

[40]  Justin R. Potnick.  Enantioselective Radical Reactions , 2004 .

[41]  W. Knowles.  Asymmetric hydrogenations (Nobel lecture). , 2002, Angewandte Chemie.

[42]  R. Sheldon.  Chirotechnology: Industrial Synthesis of Optically Active Compounds , 1993 .

[43]  H. Blaser,et al.  Chirality in Agrochemistry: An Established Technology and its Impact on the Development of Industrial Stereoselective Catalysis , 1999 .

[44]  Y. Izumi,et al.  An Asymmetric Catalyst , 1956, Nature.

[45]  P. Dalko,et al.  In the Golden Age of Organocatalysis , 2005 .

[46]  Y. Izumi,et al.  IMPROVED MODIFIED RANEY NICKEL CATALYST FOR ENANTIOFACE-DIFFERENTIATING (ASYMMETRIC) HYDROGENATION OF METHYL ACETOACETATE , 1978 .

[47]  M. Burk.  Modular phospholane ligands in asymmetric catalysis. , 2000, Accounts of chemical research.

[48]  G. Lin,et al.  A highly efficient and practical new PEG-bound bi-cinchona alkaloid ligand for the catalytic asymmetric aminohydroxylation of alkenes , 2004 .

[49]  A. Rouhi.  CHIRAL BUSINESS: Fine chemicals companies are jockeying for position to deliver the increasingly complicated chiral small molecules of the future , 2003 .

[50]  C. Barbas,et al.  Amino acid catalyzed direct asymmetric aldol reactions: a bioorganic approach to catalytic asymmetric carbon-carbon bond-forming reactions. , 2001, Journal of the American Chemical Society.

[51]  D. Blackmond,et al.  Mechanistic investigation leads to a synthetic improvement in the hydrolytic kinetic resolution of terminal epoxides. , 2004, Journal of the American Chemical Society.

[52]  Mark E. Davis,et al.  Catalysis for Environmentally Benign Processing , 1994 .

[53]  L. Paquette.  Chiral reagents for asymmetric synthesis , 2003 .

[54]  Koichi Ito,et al.  ASYMMETRIC REDUCTION OF ALIPHATIC KETONES WITH THE REAGENT PREPARED FROM (S)-(-)-2-AMINO-3-METHYL-1,1-DIPHENYLBUTAN-1-OL AND BORANE , 1984 .

[55]  K. Janda,et al.  Enantioreversal in the sharpless asymmetric epoxidation reaction controlled by the molecular weight of a covalently appended achiral polymer. , 2005, The Journal of organic chemistry.

[56]  Andrube Harrington,et al.  Twenty Years of Naproxen Technology , 1997 .

[57]  B. Pugin,et al.  Progress in enantioselective catalysis assessed from an industrial point of view , 2005 .

[58]  R. Ward.  Dynamic Kinetic Resolution , 1996 .

[59]  Asymmetric Hydrogenation of Methyl Benzoylformate Using Platinum-Carbon Catalysts Modified with Cinchonidine , 1979 .

[60]  Xumu Zhang,et al.  New Chiral Phosphorus Ligands for Enantioselective Hydrogenation , 2003 .

[61]  J. Weiner,et al.  Fundamentals and applications , 2003 .

[62]  K. Nicolaou,et al.  Total synthesis of apoptolidin: completion of the synthesis and analogue synthesis and evaluation. , 2003, Journal of the American Chemical Society.

[63]  J. Bäckvall,et al.  Racemisation in asymmetric synthesis. Dynamic kinetic resolution and related processes in enzyme and metal catalysis , 2001 .

[64]  E. Corey,et al.  Reduction of Carbonyl Compounds with Chiral Oxazaborolidine Catalysts: A New Paradigm for Enantioselective Catalysis and a Powerful New Synthetic Method , 1998 .

[65]  M. Burk,et al.  Me-DuPHOS-Rh-Catalyzed Asymmetric Synthesis of the Pivotal Glutarate Intermediate for Candoxatril. , 1999, The Journal of organic chemistry.

[66]  Jaemoon Yang,et al.  Influence of a β-Alkoxy Substituent on the CH Activation Chemistry of Alkyl Ethers , 2003 .

[67]  Iwao Ojima,et al.  Catalytic Asymmetric Synthesis: Ojima/Asymmetric Synthesis , 2005 .

[68]  R. Holt.  Microbial asymmetric reduction in the synthesis of a drug intermediate , 1996 .

[69]  P. Dalko,et al.  Enantioselective Organocatalysis. , 2001, Angewandte Chemie.

[70]  E. Corey,et al.  Reduction of Carbonyl Compounds with Chiral Oxazaborolidine Catalysts: A New Paradigm for Enantioselective Catalysis and a Powerful New Synthetic Method. , 1998, Angewandte Chemie.

[71]  Koichi Ito,et al.  Asymmetric reduction of aliphatic ketones with the reagent prepared from (S)-(−)-2-amino-3-methyl-1,1-diphenylbutan-1-ol and borane , 1984 .

[72]  C. Bolm,et al.  The MPEG effect: improving asymmetric processes by simple additives. , 2004, The Journal of organic chemistry.

[73]  H. Brown,et al.  HYDROBORATION AS A CONVENIENT PROCEDURE FOR THE ASYMMETRIC SYNTHESIS OF ALCOHOLS OF HIGH OPTICAL PURITY , 1961 .

[74]  M. Sanford,et al.  Palladium‐Catalyzed Oxygenation of Unactivated sp3 C—H Bonds. , 2004 .

[75]  H. Blaser,et al.  Sourcing chiral ligands: Issues and solutions , 2003 .

[76]  G. Sheldrake,et al.  Developments in the commercial manufacture and applications of optically active compounds , 1995 .

[77]  B. D. Vineyard,et al.  CATALYTIC ASYMMETRIC HYDROGENATION * , 1973, Annals of the New York Academy of Sciences.

[78]  Tasuku Ito,et al.  Synthesis of 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINAP), an atropisomeric chiral bis(triaryl)phosphine, and its use in the rhodium(I)-catalyzed asymmetric hydrogenation of .alpha.-(acylamino)acrylic acids , 1980 .

[79]  M. Sanford,et al.  Palladium-catalyzed oxygenation of unactivated sp3 C-H bonds. , 2004, Journal of the American Chemical Society.

[80]  H. Takaya,et al.  Asymmetric induction in carbenoid reaction by means of a dissymmetric copper chelate , 1966 .

[81]  P. Arvidsson,et al.  Rational design of asymmetric organocatalysts-increased reactivity and solvent scope with a tetrazolic acid , 2004 .

[82]  H. Kagan,et al.  The asymmetric synthesis of hydratropic acid and amino-acids by homogeneous catalytic hydrogenation , 1971 .

[83]  Tasuku Ito,et al.  SYNTHESIS OF 2,2′-BIS(DIPHENYLPHOSPHINO)-1,1′-BINAPHTHYL (BINAP), AN ATROPISOMERIC CHIRAL BIS(TRIARYL)PHOSPHINE, AND ITS USE IN THE RHODIUM(I)-CATALYZED ASYMMETRIC HYDROGENATION OF α-(ACYLAMINO)ACRYLIC ACIDS , 1981 .

[84]  Hans-Jürgen Federsel,et al.  A guide to drug discovery: Logistics of process R&D: transforming laboratory methods to manufacturing scale , 2003, Nature Reviews Drug Discovery.

[85]  J. F. Young,et al.  The preparation and properties of tris(triphenylphosphine)halogenorhodium(I) and some reactions thereof including catalytic homogeneous hydrogenation of olefins and acetylenes and their derivatives , 1966 .

[86]  J. V. Nelson,et al.  Stereoselective Aldol Condensations , 2007 .

[87]  G. Pályi,et al.  Progress in biological chirality , 2004 .

[88]  B. Pugin,et al.  Solvias Josiphos Ligands: From Discovery to Technical Applications , 2002 .

[89]  C. Claver,et al.  Ligands derived from carbohydrates for asymmetric catalysis. , 2004, Chemical reviews.

[90]  L. Yet.  Recent Developments in Catalytic Asymmetric Strecker-Type Reactions. , 2001, Angewandte Chemie.

[91]  T. Wagner,et al.  A practical building block for the synthesis of discodermolide , 2004 .

[92]  Hans-Ulrich Blaser,et al.  Enantioselective catalysis in fine chemicals production. , 2001, Chemical communications.

[93]  Mi‐jeong Kim,et al.  Highly enantioselective phase-transfer-catalytic alkylation of 2-phenyl-2-oxazoline-4-carboxylic acid tert-butyl ester for the asymmetric synthesis of alpha-alkyl serines. , 2004, Angewandte Chemie.

[94]  P. Reider,et al.  Stereoselective synthesis from a process research perspective. , 2002, Drug discovery today.

[95]  Andreas S. Bommarius,et al.  Biocatalysis: Fundamentals and Applications , 2004 .

[96]  E. Corey,et al.  The Logic of Chemical Synthesis: Multistep Synthesis of Complex Carbogenic Molecules (Nobel Lecture)† , 1991 .

[97]  L. Horner,et al.  Asymmetric Catalytic Hydrogenation with an Optically Active Phosphinerhodium Complex in Homogeneous Solution , 1968 .

[98]  D. Seebach,et al.  TADDOLs, Their Derivatives, and TADDOL Analogues: Versatile Chiral Auxiliaries. , 2001, Angewandte Chemie.

[99]  R. Daeffler,et al.  A Study of the Paterson Boron Aldol Reaction as Used in the Large-Scale Total Synthesis of the Anticancer Marine Natural Product (+)-Discodermolide , 2005 .

[100]  S. Malhotra.  Methodologies in asymmetric catalysis , 2004 .

[101]  B. Adger.  Industrial synthesis of optically active compounds , 1995 .

[102]  M. Reetz,et al.  A new principle in combinatorial asymmetric transition-metal catalysis: mixtures of chiral monodentate P ligands. , 2003, Angewandte Chemie.

[103]  L. Tietze,et al.  Enantioselective Palladium-Catalyzed Transformations , 2004 .

[104]  Roger A. Sheldon,et al.  Atom utilisation, E factors and the catalytic solution , 2000 .

[105]  A. Rouh.  CHIRAL CHEMISTRY: Traditional methods thrive because numerous hurdles, including tough luck, slow down the commercialization of catalytic processes , 2004 .

[106]  F. Koehn,et al.  The evolving role of natural products in drug discovery , 2005, Nature Reviews Drug Discovery.

[107]  B. Trost.  Asymmetric catalysis: an enabling science. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[108]  R. Sheldon.  Catalysis: The Key to Waste Minimization * , 1997 .

[109]  H. Seto,et al.  Facile synthetic access to and biological evaluation of the macrocyclic core of apoptolidin. , 2003, Organic letters.

[110]  B. D. Vineyard,et al.  Asymmetric hydrogenation. Rhodium chiral bisphosphine catalyst , 1977 .

[111]  D. Mathre,et al.  An asymmetric synthesis of MK-0417. Observations on oxazaborolidine-catalyzed reductions , 1991 .

[112]  H. Kagan,et al.  Asymmetric catalytic reduction with transition metal complexes. I. Catalytic system of rhodium(I) with (-)-2,3-0-isopropylidene-2,3-dihydroxy-1,4-bis(diphenylphosphino)butane, a new chiral diphosphine , 1972 .

[113]  N. Langlois,et al.  Reduction asymetrique catalysee par des complexes de metaux de transition IV. synthese d'amines chirales au moyen d'un complexe de rhodium et d'isopropylidene dihydroxy-2,3 bis(diphenylphosphino)-1,4 butane (diop) , 1975 .

[114]  K. Prasad,et al.  The Art of Meeting Palladium Specifications in Active Pharmaceutical Ingredients Produced by Pd-Catalyzed Reactions , 2004 .

[115]  Eric N. Jacobsen,et al.  Comprehensive asymmetric catalysis , 1999 .

[116]  Alan Williams,et al.  Opportunities for chiral agrochemicals , 1996 .

[117]  Emil Fischer,et al.  Ueber die optischen Isomeren des Traubenzuckers, der Gluconsäure und der Zuckersäure , 1890 .

[118]  John Andraos,et al.  Unification of Reaction Metrics for Green Chemistry: Applications to Reaction Analysis , 2005 .

[119]  Enamine-Based Organocatalysis with Proline and Diamines: The Development of Direct Catalytic Asymmetric Aldol, Mannich, Michael, and Diels—Alder Reactions , 2004 .

[120]  I. Ojima,et al.  Catalytic Asymmetric Synthesis , 1993 .

[121]  T. Ramsey,et al.  Large-Scale Synthesis of the Anti-Cancer Marine Natural Product (+)-Discodermolide. Part 2: Synthesis of Fragments C1-6 and C9-14 , 2004 .

[122]  B. Waldeck.  Three-dimensional pharmacology, a subject ranging from ignorance to overstatements. , 2003, Pharmacology & toxicology.

[123]  Christian Wandrey,et al.  Industrial Biocatalysis: Past, Present, and Future , 2000 .

[124]  J. Goodby.  Chirality in liquid crystals , 1991 .

[125]  Ian Paterson,et al.  A second-generation total synthesis of (+)-discodermolide: the development of a practical route using solely substrate-based stereocontrol. , 2005, The Journal of organic chemistry.

[126]  A. Chan,et al.  Recoverable catalysts for asymmetric organic synthesis. , 2002, Chemical reviews.